The Avacta Academy podcast series is a series of interviews with our CEO Chris where we are breaking donw the Nuts and Bolts of Drug Development. In this episode, our Chief Medical Officer joins to discuss the work by the clinical and translational medicine teams that is ongoing to open a trial. Now that the Company has received the Study May Proceed letter and the IND is cleared, Dave and Chris are discussing the pieces that are being assembled to open the trial.